Newsletters

This month, EGC spotlights client UT Southwestern Medical Center and its $25M ARPA-H award to advance bioprinted liver technology, shares insights on…

This month, EGC highlights our client Kernal Biologics and their $48M ARPA-H award advancing next-generation cell therapies, shares a 2026 compliance…

This month, EGC shares strategies to keep your funding moving in 2026, including insights on repositioning NIH SBIR/STTR proposals and maximizing R&D…

This month, EGC celebrates a record year of client funding and shares strategies to expand your funding opportunities. Grants Expert Brandon Turner,…

This month, we share key insights from Dr. Eva Garland on navigating funding opportunities amid the ongoing government shutdown and highlight recent…

This month, we highlight EGC’s newly released Winning NSF SBIR/STTR Grants (2nd Edition) and celebrate our client Laser Thermal for securing $5.5M in…

In this month’s newsletter, we spotlight Radar Therapeutics, awarded a CDMRP Concept Award to advance precision mRNA medicines for cancer. We also…

In this month’s newsletter, we’re gearing up for the government fiscal year-end funding surge and sharing what it could mean for your pending…

In this month’s newsletter, we highlight why a consistent grant submission strategy can pay off—even during uncertain funding cycles. We’re also…

In this month’s newsletter, we are excited to announce the launch of EGC Funding Alerts—a complimentary service offering real-time notifications of…

In this month’s newsletter, we are pleased to announce the upcoming launch of EGC Funding Alerts, a complimentary service that will provide real-time…

In this month's newsletter, we're excited to highlight the success of our client, FetTech, feature a wide range of funding opportunities from across…

In this month's newsletter, we're excited to highlight the success of our client, 10XBeta, feature a wide range of funding opportunities from across…

In this month's newsletter, we're excited to share our 2024 Impact Report, highlighting our accomplishments and the strong university partnerships…

In our first newsletter of 2025, we highlight our clients' success in securing over $320 million in non-dilutive funding. We feature our 2024…

In this final newsletter of 2024, we provide year-end financial tips to set you up for success in the year ahead and showcase exciting new SBIR/STTR…

EGC’s November newsletter announces the grand opening of our new location in Irvine, California, celebrates the success of our client, Xmark Labs,…

EGC’s October newsletter celebrates the success of our client, Dignify Therapeutics, and showcases our Fall Grant Webinar Series with two upcoming…

EGC’s September newsletter celebrates the success of our client Merlin Therapeutics and showcases two upcoming webinars – “Entity Formation Overview”…

This month we profile the success of MapHabit, a provider of personalized cognitive support for patients and caregivers. We also highlight our recent…

Client highlight: nCap Technologies is redefining what is possible with its recent Phase I Small Business Innovation Research (SBIR) award from the…

Congratulations to Jigsawdio! This innovative company is creating a multi-sensory engagement platform for people living with Alzheimer’s Disease.

Client Highlights: Congratulations to Cellforma on their recent NIH Phase I SBIR award from the National Heart, Lung, and Brain Institute (NHLBI)!

Client highlight: Congratulations to Cardiost, Inc, for being named one of only six 2023 NationalInstitute on Aging (NIA) Start-Up Challenge and…

Client highlight: EGC congratulates our client, Compact Medical, who is revolutionizing a Respiratory Bag-Valve-Mask Resuscitator to address…

EGC is pleased to assist our clients in securing and managing the funding they need to support their groundbreaking research and development.

We thank our 3,000+ clients for the privilege of being part of your journey and are thrilled to share some highlights of 2023 and new opportunities…